Burden of non-AIDS-defining and non-virus-related cancers among HIV-infected patients in the combined antiretroviral therapy era

AIDS Research and Human Retroviruses

Volumn 29, Issue 8, 2013, Pages 1097-1104

  Albini, Laura ^a   Calabresi, Alessandra ^a   Gotti, Daria ^a   Ferraresi, Alice ^a   Festa, Andrea ^a   Donato, Francesco ^a   Magoni, Michele ^b   Castelli, Francesco ^a   Quiros Roldan, Eugenia ^a  

^a UNIVERSITY OF BRESCIA   (Italy)

^b Brescia Local Health Authority   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR; NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; TENOFOVIR;

ADULT; AGED; ANTIVIRAL THERAPY; BLADDER CANCER; BRAIN CANCER; BREAST CANCER; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER REGISTRY; COLON CANCER; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KIDNEY CANCER; LARYNX CANCER; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MELANOMA; MULTIPLE MYELOMA; MYELOID LEUKEMIA; NON AIDS DEFINING CANCER; NON VIRUS RELATED CANCER; PRIORITY JOURNAL; PROSTATE CANCER; RECTUM CANCER; REFERENCE DATABASE; RETROSPECTIVE STUDY; REVIEW; SEX DIFFERENCE; SKIN CANCER; STANDARDIZED INCIDENCE RATIO; STOMACH CANCER; TESTIS CANCER; THYROID CANCER; VIRUS LOAD;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; AGED; ANTI-RETROVIRAL AGENTS; COST OF ILLNESS; FEMALE; HIV; HUMANS; INCIDENCE; ITALY; MALE; MIDDLE AGED; NEOPLASMS; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS;

EID: 84880519768     PISSN: 08892229     EISSN: 19318405     Source Type: Journal    
DOI: 10.1089/aid.2012.0321     Document Type: Review

References (48)

1. Palella FJ Jr, Delaney KM, Moorman AC, et al.. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med 1998;338(13):853-860.
2. Lewden C, May T, Rosenthal E, et al.. Changes in causes of death among adults infected by HIV between 2000 and 2005. The Mortalitè 2000 and 2005 Survey (ANRS END 19 and Mortavic). J Acquir Immune Defic Syndr 2008;48:590-598.
3. Bonnet F, Burty C, Lewden C, et al.. Changes in cancers mortality among HIV-infected patients. The Mortalitè 2005 Survey. Clin Infect Dis 2009;48:633-639.
4. Engels EA, Pfeiffer RM, Goedert JJ, et al.. Trends in cancer risk among people with AIDS in the United States 1980-2002. AIDS 2006;20:1645-1654.
5. Cooley TP. Non-AIDS-defining cancers in HIV-infected people. Hematol Oncol Clin North Am 2003;17:889-899.
6. Silverberg MJ and Abrams DI. AIDS-defining and non-AIDS defining malignancies. Cancer occurrence in the antiretroviral therapy era. Curr Opin Oncol 2007;19:446-451.
7. Polesel J, Franceschi S, Suligoi B, et al.. Cancer incidence in people with AIDS in Italy. Int J Cancer 2010;127(6):1437-1445.
8. Shiels MS, Cole SR, Kirk GD, and Poole C. A meta-analysis of the incidence of non-AIDS cancers in HIV-infected individuals. J Acquir Immune Defic Syndr 2009;52:611-622.
9. Lim ST and Levine AM. Non-AIDS-defining cancers and HIV infection. Curr HIV/AIDS Rep 2005;2:146-153.
10. Burgi A, Brodine S, Wegner S, et al.. Incidence and risk factor of occurrence of non-AIDS-defining cancers among human immunodeficiency virus-infected individuals. Cancer 2005;7. 1505-1511.
11. International Agency for Research on Cancer (IARC) Working Group on the Evolution of Carcinogenic Risks to Humans. IARC Monographs on the Evolution of Carcinogenic Risks to Humans. Volume 70. Epstein-Barr Virus and Kaposi's Sarcoma Herpes Virus/Human Herpesvirus. IARC, Lyon, France, 1997.
12. International Agency for Research on Cancer (IARC) Working Group on the Evolution of Carcinogenic Risks to Humans. IARC Monographs on the Evolution of Carcinogenic Risks to Humans. Volume 59. Hepatitis Viruses. IARC, Lyon, France, 1994.
13. International Agency for Research on Cancer (IARC) Working Group on the Evolution of Carcinogenic Risks to Humans. IARC Monographs on the Evolution of Carcinogenic Risks to Humans. Volume 90. Human Papillomaviruses. IARC, Lyon, France, 2005.
14. Clifford GM, Polesel J, Rickenbach M, et al.. Cancer risk in the Swiss HIV Cohort Study. Associations with immunodeficiency, smoking, and highly active antiretroviral therapy. J Natl Cancer Inst 2005;97:425-432.
15. Murillas J, Del Rio M, Riera M, et al.. Increased incidence of hepatocellular carcinoma (HCC) in HIV-1 infected patients. Eur J Intern Med 2005;16:113-115.
16. Baker ME, Yan L, and Pear MR. Three-dimensional model of human TIP30, a coactivator for HIV-1 Tat-activated transcription, and CC3, a protein associated with metastasis suppression. Cell Mol Life Sci 2000;57:851-858.
17. Silverberg MJ and Abrams DI. AIDS-defining and non-AIDS-defining malignancies. Cancer occurrence in the antiretroviral therapy era. Curr Opin Oncol 2007;19:446-451.
18. Rahmanian S, Wewers ME, Koletar S, Reynolds N, Ferketich A, and Diaz P. Cigarette smoking in the HIV-infected population. Proc Am Thorac Soc 2011;8(3):313-319.
19. Mani D, Haigentz M Jr, and Aboulafia DM. Lung cancer in HIV infection. Clin Lung Cancer 2012;13(1):6-13.
20. D'Jaen GA, Pantanowitz L, Bower M, et al.. HIV-associated primary lung cancer (LC) in the era of highly active antiretroviral therapy (HAART). A multi-institutional collaboration. Clin Lung Cancer 2012;11(6):396-404.
21. Puoti M, Bruno R, Soriano V, et al.. Hepatocellular carcinoma in HIV-infected patients. Epidemiological features, clinical presentation and outcome. AIDS 2004;18:2285-2293.
22. Nguyen P, Vin-Christian K, Ming ME, and Berger T. Aggressive squamous cell carcinomas in persons infected with the human immunodeficiency virus. Arch Dermatol 2002; 138:758-763.
23. Gewurz BE, Dezube BJ, and Pantanowitz L. HIV and breast. AIDS Read 2005;15:392-402.
24. Calabresi A, Ferraresi A, Limina RM, et al.. A populationbased database to study malignancies in HIV-infected patients in the Local Agency of Brescia between 1999 and 2009. Epidemiol Prev 2013 (in press).
25. Chaturvedi AK, Engels EA, Anderson WF, and Gillison ML. Incidence trends for human papillomavirus-related and-unrelated oral squamous cell carcinoma in the United States. J Clin Oncol 2008;26:612-619.
26. International Classification of Disease (ICD)-10 version. World Health Organization, 2010. http://www.who.int/classifications/icd/en/.
27. Breslow NE and Day NE. Statistical Methods in Cancer Research. The Design and Analysis of Cohort Studies. IARC scientific publication No 82, volume II. International Agency for Research of Cancer, Lyon, 1987.
28. Donato F, Limina RM, Festa A, Brunelli S, Omassi A, Guarinoni M, Zani G, Piovani F, and Salvi O. Il registro Tumori dell'ASL della Provincia di Brescia. Incidenza e mortalità per tumore maligno nell'ASL di Brescia nel triennio 1999-2001.
29. Donato F. Il registro Tumori dell'ASL della Provincia di Brescia. Incidenza e mortalità dei tumori maligni nell'ASL di Brescia nel triennio 2004-2006.
30. Associazione Italiana Registro Tumori (AIRTUM). I tumori in Italia-Rapporto AIRTUM 2010. La provenienza dei tumori in Italia. Persone che convivono con un tumore, lungosopravviventi e guariti. Epidemiol Prev 2010;34:5-6.
31. Franzetti M, Adorni F, Parravicini C, et al.. Trends and predictors of non-AIDS-defining cancers in men and women with HIV-infection. A single-institution retrospective study before and after the introduction of HAART. J Acquir Immune Defic Syndr, 2013;62(4):414-420.
32. Dubrow R, Silverberg MJ, Park LS, Crothers K, and Justice AC. HIV infection, aging, and immune function. implications for cancer risk and prevention. Curr Opin Oncol 2012; 24(5);506-516.
33. Silverberg MJ, Leyden W, Warton EM, Quesenberry CP Jr, Engels EA, and Asgari MM. HIV infection status, immunodeficiency, and the incidence of non-melanoma skin cancer. J Natl Cancer Inst 2013;105(5):350-360.
34. Franceschi S, Lise M, Clifford GM, et al.. Changing patterns of cancer incidence in the early-and late-HAART period. The Swiss HIV Cohort Study. Br J Cancer 2010;103. 416-422.
35. Engels EA, Biggar RJ, Hall HI, et al.. Cancer risk in people infected with human immunodeficiency virus in the United States. Int J Cancer 2008;123:187-194.
36. Preston-Martin S, Kirstein LM, Pogoda JM, et al.. Use of mammographic screening by HIV-infected women in the Women's Interagency HIV Study (WIHS). Prev Med 2002; 34(3):386-392.
37. Myers AM, Mccarty E, Abernathy C, and Moore GE. Breast cancer in a man with HIV infection. AIDS 1992;6:218-220.
38. Widrick P, Boguniewicz A, Nazeer T, and Remick SC. Breast cancer in a man with human immunodeficiency virus infection. Mayo Clin Proc 1997;72:761-764.
39. Chao C, Leyden WA, Xu L, et al.. Exposure to antiretroviral therapy and risk of cancer in HIV-infected persons. AIDS 2012;26(17):2223-2231.
40. Kesselring A, Gras L, Smit C, et al.. Immunodeficiency as a risk factor for non-AIDS-defining malignancies in HIV-1-infected patients receiving combination antiretroviral therapy. Clin Infect Dis 2011;52(12):1458-1465.
41. Petoumenos K, van Leuwen, Vajdic CM, et al.. Cancer, immunodeficiency and antiretroviral treatment. Results from the Australian HIV Observational Database (AHOD). HIV Med 2013;14(2):77-84.
42. Petoumenos K, Hui E, Kumarasamy N, et al.. Cancer in the TREAT Asia HIV Observational Database (TAHOD). A retrospective analysis of risk factors. J Int AIDS Soc 2010;13:51.
43. Powels T, Robinson D, Stebbing J, et al.. Highly active antiretroviral therapy and incidence of non-AIDS-defining cancers in people with HIV infection. J Clin Oncol 2009;27. 884-890.
44. Kennedy AR. Chemopreventive agents. Protease inhibitors. Pharmacol Therapeut 1998;78:167-209.
45. Sciamanna I, Landriscina M, Pitoggi C, et al.. Inhibition of endogenous reverse transcriptase antagonizes human tumor growth. Oncogene 2005;24:3923-3931.
46. Powels T, Thirwell C, Newsom-Davis T, et al.. Does HIV adversely influence the outcome in advanced non-small-cell lung cancer in the era of HAART? Br J Cancer 2003;89:457-459.
47. Lavole A, Massiani MA, Wislez M, et al.. Lung cancer in HIV-infected patients in the era of HAART. A case control study focusing on prognostic factor of survival. Lung Cancer 2000;41:S3-S314.
48. Dal Maso L, Polesel J, Serraino D, et al.. Pattern of cancer risk in persons with AIDS in Italy in the HAART era. Br J Cancer 2009;100:840-847.